Avrobio's Series B Round

Avrobio raised a round of funding on February 01, 2018.

Avrobio (NASDAQ: AVRO) is a provider of lentiviral-based gene therapies. The company is focused on the development of its programs in Fabry disease and acute myeloid leukemia (AML), while actively bui…

Articles about Avrobio's Series B Round: